- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 863720, 10 pages
7,8-Dihydroxyflavone Suppresses Oxidative Stress-Induced Base Modification in DNA via Induction of the Repair Enzyme 8-Oxoguanine DNA Glycosylase-1
1School of Medicine and Institute for Nuclear Science and Technology, Jeju National University, Jeju 690-756, Republic of Korea
2Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
3Aging Research Center, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea
4Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea
5Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 609-735, Republic of Korea
Received 25 May 2013; Revised 23 July 2013; Accepted 15 August 2013
Academic Editor: Peter Fu
Copyright © 2013 Ki Cheon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Ravanat, M. Berger, F. Benard, et al., “Phthalocyanine and naphthalocyanine photosensitized oxidation of 2′-deoxyguanosine: distinct type I and type II products,” Photochemistry and Photobiology, vol. 39, no. 6, pp. 809–814, 1984.
- M. Honda, Y. Yamada, M. Tomonaga, H. Ichinose, and S. Kamihira, “Correlation of urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study,” Leukemia Research, vol. 24, no. 6, pp. 461–468, 2000.
- J. W. Hyun, J. Y. Choi, H. H. Zeng et al., “Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1,” Oncogene, vol. 19, no. 39, pp. 4476–4479, 2000.
- J. W. Hyun, Y. C. Jung, H. S. Kim et al., “8-Hydroxydeoxyguanosine causes death of human leukemia cells deficient in 8-oxoguanine glycosylase 1 activity by inducing apoptosis,” Molecular Cancer Research, vol. 1, no. 4, pp. 290–299, 2003.
- A. Kikuchi, A. Takeda, H. Onodera et al., “Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy,” Neurobiology of Disease, vol. 9, no. 2, pp. 244–248, 2002.
- M. Matsui, C. Nishigori, S. Toyokuni et al., “The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease,” Journal of Investigative Dermatology, vol. 113, no. 1, pp. 26–31, 1999.
- S. Sato, Y. Mizuno, and N. Hattori, “Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease,” Neurology, vol. 64, no. 6, pp. 1081–1083, 2005.
- L. L. Wu, C. Chiou, P. Chang, and J. T. Wu, “Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 1–9, 2004.
- B. Halliwell, “Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life,” Plant Physiology, vol. 141, no. 2, pp. 312–322, 2006.
- S. Boiteux, T. R. O'Connor, F. Lederer, A. Gouyette, and J. Laval, “Homogeneous Escherichia coli FPG protein. A DNA glycosylase which excises imidazole ring-opened purines and nicks DNA at apurinic/apyrimidinic sites,” Journal of Biological Chemistry, vol. 265, no. 7, pp. 3916–3922, 1990.
- H. E. Krokan, H. Nilsen, F. Skorpen, M. Otterlei, and G. Slupphaug, “Base excision repair of DNA in mammalian cells,” FEBS Letters, vol. 476, no. 1-2, pp. 73–77, 2000.
- M. Bogliolo, E. Cappelli, A. D'Osualdo et al., “Effect of S. cerevisiae APN1 protein on mammalian DNA base excision repair,” Anticancer Research, vol. 23, no. 5, pp. 3727–3734, 2003.
- N. C. de Souza-Pinto, L. Eide, B. A. Hogue et al., “Repair of 8-oxodeoxyguanosine lesions in mitochondrial DNA depends on the oxoguanine DNA glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial DNA of OGG1-defective mice,” Cancer Research, vol. 61, no. 14, pp. 5378–5381, 2001.
- A. Dhénaut, S. Boiteux, and J. P. Radicella, “Characterization of the hOGG1 promoter and its expression during the cell cycle,” Mutation Research, vol. 461, no. 2, pp. 109–118, 2000.
- E. Ueta, E. Sasabe, Z. Yang, T. Osaki, and T. Yamamoto, “Enhancement of apoptotic damage of squamous cell carcinoma cells by inhibition of the mitochondrial DNA repairing system,” Cancer Science, vol. 99, no. 11, pp. 2230–2237, 2008.
- Y. S. Keum, “Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes,” Biomolecules & Therapeutics, vol. 20, no. 2, pp. 144–151, 2012.
- K. Itoh, T. Chiba, S. Takahashi et al., “An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements,” Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 313–322, 1997.
- K. Nakaso, H. Yano, Y. Fukuhara, T. Takeshima, K. Wada-Isoe, and K. Nakashima, “PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells,” FEBS Letters, vol. 546, no. 2-3, pp. 181–184, 2003.
- L. Wang, Y. Chen, P. Sternberg, and J. Cai, “Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1671–1678, 2008.
- D. Tasdemir, M. Kaiser, R. Brun et al., “Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, pp. 1352–1364, 2006.
- R. Zhang, K. A. Kang, M. J. Piao et al., “Preventive effect of 7,8-dihydroxyflavone against oxidative stress induced genotoxicity,” Biological and Pharmaceutical Bulletin, vol. 32, no. 2, pp. 166–171, 2009.
- W. A. Pryor, K. Stone, L. Zang, and E. Bermúdez, “Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage,” Chemical Research in Toxicology, vol. 11, no. 5, pp. 441–448, 1998.
- J. I. Murray, M. L. Whitfield, N. D. Trinklein, R. M. Myers, P. O. Brown, and D. Botstein, “Diverse and specific gene expression responses to stresses in cultured human cells,” Molecular Biology of the Cell, vol. 15, no. 5, pp. 2361–2374, 2004.
- K. A. Kang, K. H. Lee, S. Chae et al., “Eckol isolated from Ecklonia cava attenuates oxidative stress induced cell damage in lung fibroblast cells,” FEBS Letters, vol. 579, no. 28, pp. 6295–6304, 2005.
- L. Struthers, R. Patel, J. Clark, and S. Thomas, “Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues,” Analytical Biochemistry, vol. 255, no. 1, pp. 20–31, 1998.
- K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001.
- J. Carmichael, W. G. DeGraff, and A. F. Gazdar, “Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing,” Cancer Research, vol. 47, no. 4, pp. 936–942, 1987.
- A. Valavanidis, T. Vlachogianni, and C. Fiotakis, “8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis,” Journal of Environmental Science and Health C, vol. 27, no. 2, pp. 120–139, 2009.
- P. Fortini, B. Pascucci, E. Parlanti, M. D'Errico, V. Simonelli, and E. Dogliotti, “8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways,” Mutation Research, vol. 531, no. 1-2, pp. 127–139, 2003.
- J. Mo, Y. Xia, T. J. Wade et al., “Chronic arsenic exposure and oxidative stress: OGG1 expression and arsenic exposure, nail selenium, and skin hyperkeratosis in inner Mongolia,” Environmental Health Perspectives, vol. 114, no. 6, pp. 835–841, 2006.
- S. S. David, V. L. O'Shea, and S. Kundu, “Base-excision repair of oxidative DNA damage,” Nature, vol. 447, no. 7147, pp. 941–950, 2007.
- M. V. Ruchko, O. M. Gorodnya, A. Zuleta, V. M. Pastukh, and M. N. Gillespie, “The DNA glycosylase Ogg1 defends against oxidant-induced mtDNA damage and apoptosis in pulmonary artery endothelial cells,” Free Radical Biology and Medicine, vol. 50, no. 9, pp. 1107–1113, 2011.
- D. Liu, D. L. Croteau, N. Souza-Pinto et al., “Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 2, pp. 680–692, 2011.
- H. Motohashi, F. Katsuoka, J. D. Engel, and M. Yamamoto, “Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6379–6384, 2004.
- M. McMahon, K. Itoh, M. Yamamoto, and J. D. Hayes, “Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression,” Journal of Biological Chemistry, vol. 278, no. 24, pp. 21592–21600, 2003.
- T. W. Kensler, N. Wakabayashi, and S. Biswal, “Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89–116, 2007.
- G. P. Sykiotis and D. Bohmann, “Stress-activated cap“n”collar transcription factors in aging and human disease,” Science Signaling, vol. 3, no. 112, p. re3, 2010.
- K. Itoh, K. I. Tong, and M. Yamamoto, “Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles,” Free Radical Biology and Medicine, vol. 36, no. 10, pp. 1208–1213, 2004.
- A. Boutten, D. Goven, E. Artaud-Macari, J. Boczkowski, and M. Bonay, “NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease,” Trends in Molecular Medicine, vol. 17, no. 7, pp. 363–371, 2011.
- V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” American Journal of Physiology, vol. 279, no. 6, pp. L1005–L1028, 2000.
- J. Pi, W. Qu, J. M. Reece, Y. Kumagai, and M. P. Waalkes, “Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide,” Experimental Cell Research, vol. 290, no. 2, pp. 234–245, 2003.
- J. W. Lee, J. M. Hanson, W. A. Chu, and J. A. Johnson, “Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 20011–20016, 2001.
- D. Martin, A. I. Rojo, M. Salinas et al., “Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 8919–8929, 2004.
- Y. J. Surh, J. K. Kundu, and H. K. Na, “Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals,” Planta Medica, vol. 74, no. 13, pp. 1526–1539, 2008.
- S. Papaiahgari, Q. Zhang, S. R. Kleeberger, H. Cho, and S. P. Reddy, “Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-P13K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells,” Antioxidants and Redox Signaling, vol. 8, no. 1-2, pp. 43–52, 2006.
- J. E. Le Belle, N. M. Orozco, A. A. Paucar et al., “Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner,” Cell Stem Cell, vol. 8, no. 1, pp. 59–71, 2011.
- Ö. Erdogdu, D. Nathanson, Å. Sjöholm, T. Nyström, and Q. Zhang, “Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor,” Molecular and Cellular Endocrinology, vol. 325, no. 1-2, pp. 26–35, 2010.